Albert Bourla is Chairman and Chief Executive Officer of Pfizer Inc (PFE). The company reported total compensation of $27,585,301 for fiscal year 2025.
| Salary | $1,800,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $9,442,705 |
| Option awards | $8,998,141 |
| Non-equity incentive plan | $5,400,000 |
| Pension and non-qualified deferred compensation | $4,014 |
| All other compensation | $1,940,441 |
| Total | $27,585,301 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Pfizer Inc filed March 12, 2026, accession 0000078003-26-000033.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman and Chief Executive Officer | $1,800,000 | $0 | $9,442,705 | $8,998,141 | $5,400,000 | $4,014 | $1,940,441 | $27,585,301 |
| FY2024 | Chairman and Chief Executive Officer | $1,800,000 | $0 | $4,838,694 | $9,993,969 | $7,020,000 | $0 | $996,064 | $24,648,727 |
| FY2023 | Chairman and Chief Executive Officer | $1,787,500 | $0 | $8,745,187 | $8,761,683 | $0 | $8,440 | $2,259,254 | $21,562,064 |
| FY2022 | Chairman and Chief Executive Officer | $1,737,500 | $0 | $9,296,191 | $9,526,444 | $7,650,000 | $2,473,747 | $2,333,571 | $33,017,453 |
| FY2021 | Chairman and Chief Executive Officer | $1,687,500 | $0 | $6,180,808 | $7,050,649 | $8,000,000 | $49,901 | $1,384,361 | $24,353,219 |
Totals as disclosed in each year's own compensation disclosure for Pfizer Inc.
| Peer-group chief executive median | $28,437,198 |
|---|---|
| Difference from that median | $-851,897 |
| Percentile within the disclosed peer group | 43rd |
| Peers with a disclosed figure | 7 |
Medians and percentiles are computed across the peer group Pfizer Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Albert Bourla this page | Chairman and Chief Executive Officer | $27,585,301 |
| Chris Boshoff | Chief Scientific Officer and President, Research & Development | $10,006,039 |
| David Denton | Chief Financial Officer, Executive Vice President | $9,670,182 |
| Aamir Malik | Chief U.S. Commercial Officer, Executive Vice President | $9,429,227 |
| Douglas Lankler | Chief Legal Officer, Executive Vice President | $9,106,276 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Pfizer Inc compensation brief.
Albert Bourla's compensation sits inside Pfizer Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.